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The isolation and primary structure of a novel gastrointestinal peptide, designated valosin, is described. The 
peptide was purified from porcine upper gut extracts using an HPLC and N-terminal sequence screening 
strategy which depends on chromatographic and structural characteristics as isolation criterion. The amino 
acid sequence of this peptide consists of 25 amino acid residues: 
VQYPVEHPDKFLKFGMTPSKGVLFY. 
It does not show structural homology to known protein or nucleotide sequences. According to preliminary 
experiments, valosin possesses biological effects on the gastrointestinal tract of the dog. 
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1. INTRODUCTION 
A number of gastrointestinal peptides, for in- 
stance PHI [l], PYY [2] and galanin [3], have been 
isolated from porcine intestinal extracts using a 
chemical assay based on the detection of the C- 
terminal amide structure without having any infor- 
mation on a biological activity [4]. Subsequent 
studies revealed that these peptides have biological 
activities and may exert endocrine or neurocrine 
regulatory functions in the gut and brain of dif- 
ferent species. Since not all biologically active pep- 
tides contain a C-terminal amide, e.g. glucagon, 
motilin, GIP, somatostatin and neurotensin, we 
used a screening strategy which is dependent on 
chromatographic behaviour, UV-absorbance char- 
acteristics and N-terminal sequence determination 
to isolate and characterize novel peptides from 
porcine intestinal tissue extracts. While in- 
vestigating side-fractions arising from the purifica- 
tion scheme for PHI and secretin, we identified a 
novel peptide with an HPLC retention time dif- 
ferent from the known gastrointestinal peptides. 
We report here the isolation and structural 
characterization of this novel gastrointestinal pep- 
tide which we have designated ‘valosin’ from N- 
terminal vAine and C-terminal tyrae. This pep- 
tide was formerly referred to as ‘peptide VQY’ in 
a preliminary account of this study [5]. 
2. MATERIALS AND METHODS 
2.1. Isolation procedures 
As starting material a side-fraction of the 
secretin purification scheme [6] was used. Briefly, 
upper porcine intestine (4.0 kg) was boiled in water 
for 10 min, frozen, minced and extracted with 
0.5 M acetic acid. Peptides were further purified 
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by adsorption to alginic acid, extraction with 66% 
ethanol, gel filtration on Sephadex G-25 and ex- 
traction with methanol. The methanol-soluble 
fraction, also containing secretin, PHI and PYY, 
was chromatographed on CM-cellulose in 
12.5 mM Na-phosphate, pH 8.0. All fractions 
eluting before secretin were pooled and used as 
starting material. This was subjected to another 
CM-cellulose column and eluted with 0.02 M 
NHdHC03 (pH 6.5) followed by 0.2 M, pH 8.0. 
All resulting fractions (I-IX) were characterized 
by HPLC on a reversed-phase C-l 8 column (Shan- 
don ODS Hypersil, 5 pm or Vydac RP-201 wide- 
pore, 300 A, 10 pm) using a Waters HPLC system 
equipped with a dual-channel UV detector (M440) 
for measurement at 214 and 280 nm. The 
chromatographic conditions are described in the 
legends to figs 2 and 3. Unknown peptide peaks 
were rechromatographed and characterized by 
HPLC retention time compared to mixtures of 
known gastrointestinal peptides. For further iden- 
tification the UV absorbance was measured at 
214 nm (sensitivity, 0.1 units) and 280 nm (0.01). 
The peaks were integrated and the ratio R of the 
areas was calculated as R = F(214/o.t)/F(280,0.0t)_ 
This ratio was considered to represent a 
characteristic value for each peptide reflecting the 
relative content of amino acids with high absorp- 
tion at 280 nm, i.e. tryptophan and tyrosine. 
2.2. Structural analysis 
Amino acid analysis was performed with a Dur- 
rum D-500 automatic amino acid analyzer after 
hydrolysis of the sample with 0.5 ml of 5.7 N HCl 
containing 0.5% phenol in evacuated tubes at 
110°C for 24 h. For sequence determination the 
peptide was cleaved by TPCK-trypsin in 0.1 M 
NH4HC03 (pH 8.2) for 6 h at 37”C, the tryptic 
fragments were isolated by HPLC. The amino acid 
sequence was determined by manual DABITC- 
Edman degradation (dimethylaminoazobenzene 
isothiocyanate method) [7] for N-terminal se- 
quence screening and for sequencing of the tryptic 
peptides. Liquid-phase sequencer degradation on a 
Beckman model 890 with spinning-cup modifica- 
tion [8] and gas-phase sequencing on an Apphed 
Biosystems model 470A [9], both in the presence of 
polybrene [lo], were used for the intact peptide 
and the tryptic peptide T4. The phenylthiohydan- 
toin derivatives were identified by HPLC on a 
reversed-phase microbore column [l 11. The ob- 
tained primary structures were screened for se- 
quence homology against the Dayhoff’s Protein 
Segment Dictionary [12] and against the protein 
and nucleotide sequence data bank constructed by 
Doolittle et al. [13]. 
3. RESULTS 
3.1. Isolation of the peptide 
Fig. 1 shows the ion-exchange chromatography 
on CM-cellulose in 0.02 M and subsequently 
0.2 M ammonium bicarbonate of the ‘presecretin’ 
fraction. Fractions l-IX were collected and fur- 
ther separated by reversed-phase HPLC. The pep- 
tide peaks were characterized by their HPLC reten- 
tion times in a trifluoroacetic acid (TFA)/aceto- 
nitrile system (see fig.2 legend) and by the ratio of 
UV absorbance at 214 and 280 nm. Using this 
strategy combined with a screening N-terminal 
sequence determination of the first 4-6 residues by 
manual DABITC-Edman degradation, a novel 
peptide could be identified in fraction VI of the 
CM-cellulose chromatography. Fig.2 shows the 
HPLC elution profile of this fraction. Further- 
more, chromatographic and sequence analysis un- 
equivocally identified in fraction VI some other 
peptide peaks additional to the well-characterized 
peptides PYY, secretin and PHI, as marked in 
fig.2. Rechrbmatography of the peak, preliminari- 
ly designated VQY on the basis of the first 3 
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Fig. 1. Cation-exchange chromato~aphy of the starting 
material (2.0 g) on a CM-cellulose column (5 x 15 cm) 
in 0.02 M/0.2 M N&HCOs. Flow rate, 10 ml/min; 
fractions I-IX were further characterized. 
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Fig.2. HPLC elution profile of fraction VI from rht 
CM-cellulose chromatography (fig.1). 0.6 mg was 
applied to a Shandon ODS Hypersil reversed-phase C-18 
column (5 pm, 0.46 x 25 cm) and eluted at 40°C using 
a linear gradient from 45 to 65% solvent B. Flow rate, 
1.5 ml/min; solvent A, 0.1% TFA; solvent B, 0.12% 
TFA in 70% acetonitrile. PYY, secretin and PHI were 
identified by retention-time analysis and confirmed by 
N-terminal sequence determination, the peak marked 
VQY contained the peptide valosin. UV absorbance at 
214 and 280 nm (not shown) was measured. 
residues, on a reversed-phase C-18 wide-pore col- 
umn, using a shallow gradient in the TFA/ace- 
tonitrile system, resulted in isolation of the peptide 
in essentially pure form as shown by the elution 
profile in fig.3. 
3.2. Structural analysis 
The amino acid analysis (table 1) revealed that 
the peptide consists of 25 amino acid residues. 
Based on its N- and C-terminal amino acids (valine - 
and tyrme, respectively) the name valosin is pro- 
posed for this peptide. The tryptic fragments 
Tl-T4 were isolated by HPLC using the same 
system as described in the legend to fig.%, their 
amino acid compositions being listed in table 1. 
Using manual DABITC-Edman degradation, the 
primary structures of the peptides Tl, T2 and T3 
were completely established and the intact peptide 
could be sequenced up to position 18 by liquid- 
phase sequencing. Due to its substantial 
hydrophobicity, peptide T4 was washed out after 
step 2 of sequencing with both methods. However, 
using the gas-phase sequencing technique, the 
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Fig.3. HPLC rechromatography of the peak containing 
peptide valosin (VQY) on a Vydac RP-201 C-18 wide- 
pore column (300 A, 1Orm) using the same solvent 
system as described in fig.1. Peptide valosin eluted in 
pure form as indicated by the absorbance profile read at 
214 and 280 nm. 
Table 1 
Amino acid composition of peptide valosin and its 
tryptic fragments Tl, T2, T3 and T4 
Valosin Tl T2 T3 T4 
A$X 1.2 (1) 
Thr 1.0 (1) 
Ser 1.0 (1) 
Glx 2.3 (2) 
Pro 3.1 (3) 
GUY 2.1 (2) 
Val 2.8 (3) 
Met 0.9 (1) 
Leu 2.1 (2) 
T yr 1.9 (2) 
Phe 2.9 (3) 
His 1.0 (1) 
Lys 2.9 (3) 
Sum 25 
1.1 (1) 
0.9 (I) 
1.2 (1) 
2.1 (2) 
2.1 (2) 
1.8 (2) 
1.0 (1) 
0.8 (1) 
1.1 (1) 
10 
0.9 (1) 
1.3 (1) 1.2 (1) 
0.9 (1) 
0.8 (1) 
1.2 (1) 0.8 (1) 
1.0 (1) 
0.8 (1) 0.9 (1) 1.0 (1) 
1.0 (1) 1.1 (1) 
3 7 5 
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Fig.4. The complete primary structure of peptide valosin 
(VQY) and its tryptic fragments Tl-T4. 
complete amino acid sequence of peptide T4 and 
of intact valosin was elucidated as shown in fig.4, 
using 1.0 and 0.5 nmol, respectively. The C- 
terminus of both peptides was not amidated. 
4. DISCUSSION 
Using an HPLC- and N-terminal sequence 
screening strategy, a peptide with a novel primary 
structure was isolated from highly purified peptide 
fractions derived from porcine intestinal extracts. 
The amino acid sequence was searched for struc- 
tural homology against Dayhoff’s Protein Seg- 
ment Dictionary [12] and against the protein and 
nucleotide sequence data bank of Doolittle et al. 
[ 131: no convincing homology was found to any 
known peptide or protein sequence except from 
coincidentally identical residues. It appears, 
therefore, that valosin is a novel peptide and may 
be a member of an as yet unidentified family of 
gastrointestinal peptides. 
In preliminary screening experiments looking 
for biological effects in dogs equipped either with 
pancreatic fistulas or with implanted electrodes 
along the small bowel, the peptide valosin seemed 
to exert a dose-dependent CCK- or bombesin-like 
stimulatory action on exocrine pancreatic secre- 
tion, whereas the appearance of the slow migrating 
myoelectric complexes in different parts of the in- 
testine was delayed [5]. Despite the preliminary 
character of these biological studies, the results 
may point to a regulatory function for valosin in 
the gastrointestinal tract. 
As yet, however, the possibility cannot be ex- 
cluded that the peptide valosin will be identified as 
a fragment of a hitherto unknown protein in the 
gut, since other protein fragments, e.g. from a- 
chain of hemoglobin, have been shown to exhibit 
certain biological actions [ 14,151. 
Immunocytochemical studies on the distribution 
within the gut and molecular cloning of the precur- 
sor molecule of peptide valosin should help to 
clarify its role in the gastrointestinal tract. 
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